Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

558.87
+13.412.46%
Post-market: 562.994.12+0.74%19:55 EDT
Volume:1.66M
Turnover:920.76M
Market Cap:60.34B
PE:14.17
High:583.28
Open:583.01
Low:542.89
Close:545.46
Loading ...

Regeneron Reports 4% Revenue Growth, 3% GAAP EPS Increase, and 12% Non-GAAP EPS Rise in Q2 2025

Reuters
·
01 Aug

Regeneron Outlook FY Capex USD 880-950 Million

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals Inc: Total Eylea Hd and Eylea U.S. Net Sales Decreased 25% to $1.15 Bln in Q2

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals Inc: Dupixent Global Net Sales (Recorded by Sanofi) Increased 22% to $4.34 Bln in Q2

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals: on July 30, FDA Issued a Complete Response Letter for Bla for Odronextamab

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals: Expects Regulatory Approvals to Be Delayed for Its Currently Pending FDA Applications for Eylea Hd

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals: Eylea Hd Regulatory Delay Related to Observations From FDA General Site Inspection at Catalent Indiana Llc

THOMSON REUTERS
·
01 Aug

Regeneron Reports Second Quarter 2025 Financial and Operating Results

GlobeNewswire
·
01 Aug

Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga
·
01 Aug

BUZZ-Pharmaceutical shares fall after White House says Trump urging cos to lower drug costs

Reuters
·
01 Aug

Sanofi sees 'manageable' impact from US tariffs, expects strong sales growth

Reuters
·
31 Jul

CORRECTED-AstraZeneca's eco-friendly version of smoker's lung inhaler gets EU panel backing

Reuters
·
25 Jul

Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation

GlobeNewswire
·
24 Jul

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 Jul

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
19 Jul

Lilly's Zepbound Faces a Potential Weight-Loss Rival. It's Made by a Chinese Biotech. -- Barrons.com

Dow Jones
·
16 Jul

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-15

Reuters
·
15 Jul

Accelerated FDA Approval of Lynozyfic May Change the Case for Investing in Regeneron (REGN)

Simply Wall St.
·
12 Jul

Regeneron Pharma Is Maintained at Neutral by UBS

Dow Jones
·
12 Jul

Regeneron Pharmaceuticals Launches Long-Term Follow-Up Study on Gene Modified T Cell Therapy

TIPRANKS
·
12 Jul